Simplex Trading
CRSP icon

Simplex Trading’s CRISPR Therapeutics CRSP Stock Holding History

Simplex Trading’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.9K Buy
+1,407
New +$74.2K ﹤0.01% 5538
2025
Q1 		– Sell
-83,134
Closed -$3.52M – 8665
2024
Q4 		$3.27M Buy
83,134
+16,254
+24% +$768K ﹤0.01% 1787
2024
Q3 		$3.14M Buy
+66,880
New +$3.39M ﹤0.01% 1883
2023
Q4 		– Sell
-34,794
Closed -$1.92M – 8921
2023
Q3 		$1.58M Buy
34,794
+32,454
+1,387% +$1.68M ﹤0.01% 2284
2023
Q2 		$131K Sell
2,340
-13,437
-85% -$762K ﹤0.01% 4760
2023
Q1 		$713K Buy
15,777
+9,919
+169% +$482K ﹤0.01% 2913
2022
Q4 		$238K Buy
5,858
+3,518
+150% +$187K ﹤0.01% 4016
2022
Q3 		$152K Hold
2,340
– – ﹤0.01% 4968
2022
Q2 		$142K Sell
2,340
-14,298
-86% -$841K ﹤0.01% 5071
2022
Q1 		$1.04M Buy
16,638
+3,217
+24% +$202K ﹤0.01% 2868
2021
Q4 		$1.02M Sell
13,421
-1,765
-12% -$154K ﹤0.01% 2828
2021
Q3 		$2.38M Buy
15,186
+412
+3% +$51.7K ﹤0.01% 1943
2021
Q2 		$2.39M Buy
14,774
+12,794
+646% +$1.56M ﹤0.01% 1938
2021
Q1 		$241K Sell
1,980
-11,953
-86% -$1.8M ﹤0.01% 4458
2020
Q4 		$2.13M Buy
+13,933
New +$1.65M ﹤0.01% 1718
2020
Q3 		– Sell
-5,082
Closed -$451K – 7869
2020
Q2 		$373K Buy
5,082
+4,991
+5,485% +$292K ﹤0.01% 3259
2020
Q1 		$3K Buy
+91
New +$4.7K ﹤0.01% 7040
2018
Q2 		– Sell
-20,015
Closed -$1.14M – 7427
2018
Q1 		$914K Buy
20,015
+17,247
+623% +$712K 0.04% 428
2017
Q4 		$64K Sell
2,768
-555
-17% -$10.5K ﹤0.01% 2196
2017
Q3 		$59K Buy
+3,323
New +$60.3K ﹤0.01% 2149

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Simplex Trading's CRSP Position: Q1 2026 in Review

Simplex Trading opened a new position in CRISPR Therapeutics (CRSP) in Q1 2026: 1,407 shares worth $66.9K. The stake represents ﹤0.01% of the portfolio and ranks #5538 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CRSP as recently as Q4 2024.

Simplex Trading first reported a position in CRSP in Q3 2017 and has held it in 20 quarters since. The position peaked at $3.27M in Q4 2024. 488 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • Simplex Trading held 1,407 shares of CRISPR Therapeutics worth $66.9K as of Q1 2026.
  • CRISPR Therapeutics was a new Simplex Trading position in Q1 2026.
  • CRISPR Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5538 holding.
  • Simplex Trading first reported a position in CRISPR Therapeutics in Q3 2017 and has held it in 20 quarters since.
  • Simplex Trading's CRISPR Therapeutics position peaked at $3.27M in Q4 2024.
  • 488 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.